BCAL Diagnostics has partnered with researches in the United States to develop its blood-based breast cancer test technology.

Cancer move for local resources companies

Two Perth-based resources companies are planning to switch sectors with the acquisition of cancer-based biotechnology firms, with one planning a backdoor listing and the other seeking support for an IPO.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLPC cresa

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer